Tim Cross

2.7k total citations
20 papers, 270 citations indexed

About

Tim Cross is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Tim Cross has authored 20 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 11 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Tim Cross's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver Disease and Transplantation (5 papers). Tim Cross is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver Disease and Transplantation (5 papers). Tim Cross collaborates with scholars based in United Kingdom and India. Tim Cross's co-authors include Dinesh Jothimani, Mark Ellul, Matthew Cramp, R. Driver, Anya Burton, Ian Rowe, Daniel H. Palmer, U. Warshow, Gary Minto and Aileen Marshall and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Tim Cross

20 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Cross United Kingdom 9 154 137 112 56 30 20 270
Cheng-Shyong Wu Taiwan 8 111 0.7× 118 0.9× 123 1.1× 56 1.0× 55 1.8× 10 319
Hugh J. Kennedy United Kingdom 6 177 1.1× 228 1.7× 117 1.0× 83 1.5× 23 0.8× 9 376
Ryuta Shigefuku Japan 10 115 0.7× 167 1.2× 43 0.4× 53 0.9× 37 1.2× 41 294
Andrzej Habior Poland 11 164 1.1× 205 1.5× 102 0.9× 56 1.0× 17 0.6× 34 361
Suzanne van Meer Netherlands 10 209 1.4× 200 1.5× 188 1.7× 45 0.8× 43 1.4× 15 484
Omair Atiq United States 4 188 1.2× 213 1.6× 84 0.8× 93 1.7× 101 3.4× 9 381
Carlos Romero‐Marrero United States 9 225 1.5× 187 1.4× 140 1.3× 33 0.6× 26 0.9× 35 336
David M. Chascsa United States 11 216 1.4× 151 1.1× 115 1.0× 126 2.3× 22 0.7× 33 372
Yohji Honda Japan 15 285 1.9× 224 1.6× 130 1.2× 60 1.1× 60 2.0× 25 461
Antonio Di Micoli Italy 10 374 2.4× 292 2.1× 125 1.1× 39 0.7× 44 1.5× 25 502

Countries citing papers authored by Tim Cross

Since Specialization
Citations

This map shows the geographic impact of Tim Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Cross more than expected).

Fields of papers citing papers by Tim Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Cross. The network helps show where Tim Cross may publish in the future.

Co-authorship network of co-authors of Tim Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Cross. A scholar is included among the top collaborators of Tim Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Cross. Tim Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burton, Anya, Jennifer Wilburn, R. Driver, et al.. (2024). Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality. British Journal of Cancer. 130(10). 1697–1708. 4 indexed citations
2.
Elsharkawy, Ahmed M., Ingeborg Steinbach, William Stableforth, et al.. (2023). P136 The carbon impact of poster exhibitions at a UK medical conference; comparative analysis of different models. Poster presentations. A105–A105. 1 indexed citations
3.
Hydes, Theresa, Charmaine Matthews, Vinay Kumar, et al.. (2022). P21 Lack of NAFLD-related hepatocellular carcinoma surveillance may explain more advanced stage at diagnosis and worse median survival. Abstracts. A46–A47. 1 indexed citations
4.
Burton, Anya, R. Driver, Lizz Paley, et al.. (2021). Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England. British Journal of Cancer. 126(5). 804–814. 16 indexed citations
5.
Burton, Anya, R. Driver, Thomas G. Bird, et al.. (2021). Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation. JHEP Reports. 3(2). 100232–100232. 40 indexed citations
6.
Gwozdz, Adam, Tim Cross, Kamran Ahmed, et al.. (2021). 30-Day postoperative COVID-19 outcomes in 398 patients from regional hospitals utilising a designated COVID-19 minimal surgical site pathway. Annals of The Royal College of Surgeons of England. 103(6). 395–403. 2 indexed citations
7.
Alabraba, Edward, Heman Joshi, N. Bird, et al.. (2019). Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. European Journal of Surgical Oncology. 45(9). 1660–1667. 50 indexed citations
8.
9.
Ellul, Mark, et al.. (2018). Hepatic encephalopathy: current challenges and future prospects. SHILAP Revista de lepidopterología. Volume 10. 1–11. 40 indexed citations
10.
Au, Lewis, Rooshi Nathwani, Lucia Possamai, et al.. (2018). Pathogenesis, clinical evolution and outcomes of patients with immune checkpoint inhibitor induced acute liver injury: A multicentre study. Annals of Oncology. 29. viii430–viii430. 1 indexed citations
11.
Cross, Tim & Daniel H. Palmer. (2018). Liver Cancers. 1 indexed citations
12.
Toyoda, Hideki, Takashi Kumada, Nóra Schweitzer, et al.. (2017). Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study. Journal of Hepatology. 66(1). S620–S621. 1 indexed citations
13.
Cross, Tim. (2016). Liver Disease in Clinical Practice. DIAL (Catholic University of Leuven). 1 indexed citations
14.
Cross, Tim, et al.. (2016). Factors influencing the length of stay for breast cancer patients undergoing mastectomy: An independent sector perspective. European Journal of Surgical Oncology. 42(5). S23–S23. 2 indexed citations
15.
Jothimani, Dinesh, et al.. (2014). Role of Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis—An Observational Study. Journal of Clinical and Experimental Hepatology. 4(3). 221–225. 20 indexed citations
16.
17.
Erasmus, Paul, et al.. (2014). Impaired functional capacity in potential liver transplant candidates predicts short-term mortality before transplantation. Liver Transplantation. 20(9). 1081–1088. 32 indexed citations
18.
Cross, Tim, et al.. (2014). Mo1046 An External Validation of the Hepatoma Arterial-Embolisation Prognosis (Hap) Score: The Liverpool Experience. Gastroenterology. 146(5). S–995. 1 indexed citations
19.
Jothimani, Dinesh, et al.. (2010). Treatment of autoimmune hepatitis: A review of current and evolving therapies. Journal of Gastroenterology and Hepatology. 26(4). 619–627. 30 indexed citations
20.
Joshi, Deepak, Tim Cross, & Voi Shim Wong. (2007). Acute drug induced hepatitis secondary to a weight loss product purchased over the internet. Nutrition Journal. 6(1). 13–13. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng-Shyong Wu Breakdown of academic impact, for papers by Hugh J. Kennedy Breakdown of academic impact, for papers by Ryuta Shigefuku Breakdown of academic impact, for papers by Andrzej Habior Breakdown of academic impact, for papers by Suzanne van Meer Breakdown of academic impact, for papers by Omair Atiq Breakdown of academic impact, for papers by Carlos Romero‐Marrero Breakdown of academic impact, for papers by David M. Chascsa Breakdown of academic impact, for papers by Yohji Honda Breakdown of academic impact, for papers by Antonio Di Micoli
Rankless by CCL
2026